Drug Metabolism Reviews

Drug Metabolism Reviews  
Discipline Pharmaceutical Science
Language English
Publication details
Publication history
First published 1972
Publisher
Informa Pharmaceutical Science
Frequency 4 issues per year
No
5.356
Standard abbreviations
Drug Metab. Rev.
Indexing
ISSN 0360-2532 (print)
1097-9883 (web)
Links

Established in 1972, Drug Metabolism Reviews is an academic journal that publishes review articles on all aspects of drug metabolism research. It is the official journal of the International Society for the Study of Xenobiotics (ISSX).[1]

The journal is published by Informa. Jack A. Hinson, Professor and Director of the Division of Toxicology at University of Arkansas for Medical Sciences, serves as its editor-in-chief.[2][3]

Core Areas

Topics covered include:

  • established, new and potential drugs
  • environmentally toxic chemicals
  • absorption
  • metabolism and excretion
  • enzymology, including all living species.

Publication Format

The journal publishes 4 issues per year in simultaneous print and online editions. All back-issues of the journal are available online and are hosted on the publisher's website.[4]

Impact Factor

According to ISI it received an impact factor of 5.356 as reported in the 2014 Journal Citation Reports by Thomson Reuters, ranking it 16th out of 254 journals in the category “Pharmacology & Pharmacy”.[5]

References

  1. "International Society for the Study of Xenobiotics". www.issx.org. Archived from the original on 2011-07-19. Retrieved 2009-05-22.
  2. "Editorial Board Members". informapharmascience.com. Retrieved 2009-05-22.
  3. "University of Arkansas for Medical Sciences". www.uams.edu. Archived from the original on 2009-03-06. Retrieved 2009-06-10.
  4. "Informa Pharmaceutical Science brochure". informapharmascience.com. Retrieved 2009-05-22.
  5. "Journals Ranked by Impact: Pharmacology & Pharmacy". 2014 Journal Citation Reports. Web of Science (Sciences ed.). Thomson Reuters. 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.